Institute of Molecular Pharmacology, RWTH Aachen University, Aachen, Germany.
Department of Medicine III, University Hospital RWTH Aachen University, Aachen, Germany.
J Cell Mol Med. 2021 Feb;25(4):1982-1999. doi: 10.1111/jcmm.16015. Epub 2020 Dec 13.
Hepatocellular carcinoma (HCC) is one of the most common metastatic tumours. Tumour growth and metastasis depend on the induction of cell proliferation and migration by various mediators. Here, we report that the A Disintegrin and Metalloproteinase (ADAM) 8 is highly expressed in murine HCC tissues as well as in murine and human hepatoma cell lines Hepa1-6 and HepG2, respectively. To establish a dose-dependent role of different ADAM8 expression levels for HCC progression, ADAM8 expression was either reduced via shRNA- or siRNA-mediated knockdown or increased by using a retroviral overexpression vector. These two complementary approaches revealed that ADAM8 expression levels correlated positively with proliferation, clonogenicity, migration and matrix invasion and negatively with apoptosis of hepatoma cells. Furthermore, the analysis of pro-migratory and proliferative signalling pathways revealed that ADAM8 expression level was positively associated with expression of β1 integrin as well as with the activation of focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), Src kinase and Rho A GTPase. Finally, up-regulation of promigatory signalling and cell migration was also seen with a proteolytically inactive ADAM8 mutant. These findings reveal that ADAM8 is critically up-regulated in hepatoma cells contributes to cell proliferation and survival and furthermore induces pro-migratory signalling pathways independently of its proteolytic activity. By this, ADAM8 can promote cell functions most relevant for HCC growth and metastasis.
肝细胞癌 (HCC) 是最常见的转移性肿瘤之一。肿瘤的生长和转移依赖于各种介质诱导的细胞增殖和迁移。在这里,我们报告 A 型解整合素金属蛋白酶 (ADAM) 8 在小鼠 HCC 组织以及小鼠和人肝癌细胞系 Hepa1-6 和 HepG2 中均高度表达。为了建立 ADAM8 表达水平对 HCC 进展的剂量依赖性作用,我们通过 shRNA 或 siRNA 介导的敲低降低 ADAM8 的表达,或者使用逆转录病毒过表达载体增加 ADAM8 的表达。这两种互补的方法表明,ADAM8 的表达水平与肝癌细胞的增殖、集落形成、迁移和基质侵袭呈正相关,与细胞凋亡呈负相关。此外,对促迁移和增殖信号通路的分析表明,ADAM8 的表达水平与 β1 整合素的表达以及粘着斑激酶 (FAK)、丝裂原激活蛋白激酶 (MAPK)、Src 激酶和 Rho A GTPase 的激活呈正相关。最后,具有蛋白水解失活的 ADAM8 突变体也观察到促迁移信号和细胞迁移的上调。这些发现表明,ADAM8 在肝癌细胞中被显著上调,有助于细胞增殖和存活,并且独立于其蛋白水解活性诱导促迁移信号通路。通过这种方式,ADAM8 可以促进与 HCC 生长和转移最相关的细胞功能。